We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
- Authors
Qunchang Zhang; Yongtao Zhang; Ying Wang
- Abstract
Gastric carcinoma proliferation enhancing transcript 1 (GHET1) has been suggested to serve as a promising oncogenic lncRNA in various types of human cancer. However, the role of GHET1 remained unknown in cervical cancer. In our study, we found GHET1 expression was markedly elevated in cervical cancer tissue specimens and cell lines compared with adjacent normal cervical tissue specimens and human normal cervical cell line, respectively. Then, we found high expression of GHET1 is a useful biomarker to discriminate cervical cancer tissues from non-tumorous tissues, and associated with advanced clinical stage, lymph node metastasis, distant metastasis and poor histological grade in cervical cancer patients. The survival analysis showed high GHET1 expression was an independent unfavorable prognostic factor in cervical cancer patients. Knockdown of GHET1 expression markedly inhibits cervical cancer cell proliferation, migration, and invasion. The loss-of-function study indicated knockdown of GHET1 expression markedly inhibits cervical cancer cell proliferation, migration, and invasion. In conclusion, GHET1 acts as an oncogenic lncRNA in cervical cancer.
- Publication
Bioscience Reports, 2019, Vol 39, Issue 4, p1
- ISSN
0144-8463
- Publication type
Article
- DOI
10.1042/BSR20182506